Abpro Holdings, Inc.
ABPO · ABPWW · Biological Products, (No Disgnostic Substances)
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form SCHEDULE 13G/A
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-K/A
SEC filing · Filed
-
Form 10-K
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Lee Soo Young: Form 4
Insider disclosure · Filed · Report period 25 Jul 2025
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001893219 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- ABPO, ABPWW on OTC
- SEC industry group
- Biological Products, (No Disgnostic Substances) (Office of Life Sciences)
- Business address
- 6 St Johns Lane, Floor 5, New York, NY, 10013
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- Atlantic Coastal Acquisition Corp. II (to 12 Nov 2024)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields